The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

Research finds widespread synthetic dye use in US packaged foods and drinks as FDA pushes phase-out amid rising child health ...

The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...

JB Chemicals has received US FDA approval to market its generic version of Amitriptyline Hydrochloride tablets, used to treat ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

An FDA study of 110 melatonin supplements marketed for children found doses ranged from 0 to 667 percent of the amount on the ...

Drugmaker Lupin Ltd. informed the exchanges that it has received approval from the United States Food & Drug Regulator (USFDA ...

Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...

Capricor Therapeutics said on Tuesday the U.S. Food and Drug Administration has indicated that an advisory panel review may ...

U.S. Health Secretary Robert F. Kennedy Jr. fired all 17 members of a national vaccine advisory board, naming eight new ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel, set to convene on Wednesday, has ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for prucalopride ...